All French public universities should end 2026 in deficit. This historic shift occurs as Germany increases university funding by 8% in 2026 and the United Kingdom launches a rescue plan for its post-Brexit laboratories. France makes the opposite choice: ADEME loses 350 million euros in two years, the French Biodiversity Office 40 million. National R&D spending caps at 2.22% of GDP, far from the 3% promised by 2030.
This budgetary erosion sketches a clear political choice: accept French scientific decline or reverse a trajectory that threatens 20 years of academic excellence. While Berlin bets on fundamental research and London repairs the damage from Brexit, Paris lets its universities sink one by one into the red.
The Essentials
- All 75 French public universities will end 2026 in deficit, a historic first
- ADEME lost 350 million euros between 2024 and 2026, the French Biodiversity Office 40 million
- French R&D spending stagnates at 2.22% of GDP against a 3% target set for 2030
- Germany increases university funding while France reduces it
Generalized Deficit: 75 Universities in the Red for the First Time
No French public university will escape deficit in 2026. This unprecedented situation since the creation of modern universities strikes institutions previously spared. The Sorbonne shows a shortfall of 23 million euros, the University of Strasbourg 18 million, that of Lyon 1 nearly 15 million according to budget forecasts transmitted to the ministry.
Non-negotiable costs explain this collapse: energy costs up 40% since 2022, automatic wage increases, deferred maintenance of dilapidated buildings. But state allocations have not kept pace. They grow by 1.8% when inflation reaches 4.2% over the same period.
“We are managing scarcity, we are no longer running a university,” summarizes the president of a major Paris region university who prefers anonymity. Budget cuts hit research first: equipment not renewed, doctoral positions eliminated, study trips cancelled. France is repeating the British mistake of the austerity years, but without the catch-up plan that followed.
This situation contrasts sharply with Germany, where the federal government increases university funding by 8% in 2026. Berlin invests massively in fundamental research, considering that “innovation begins in laboratories.”
ADEME Gutted, French Climate Expertise Weakens
The Environment and Energy Management Agency (ADEME) loses 350 million euros between 2024 and 2026, or 18% of its budget. This massive reduction strikes the institution precisely when energy transition accelerates. Subsidies for renewable energy decrease by 200 million, climate research programs by 89 million, support for local authorities by 61 million.
The French Biodiversity Office (OFB) suffers the same fate with a cut of 40 million euros. These cuts occur while China catches up with America as the West abandons research, creating a void that Beijing hastens to fill in green technologies.
France reduces its climate expertise at the moment it should intensify it. ADEME employs 1,100 engineers and researchers specialized in energy transitions. Their work informs national and European public policies. Weakening this analytical capacity amounts to navigating blind in decarbonization.
The irony is cruel: Paris imposes energy sobriety on citizens while starving the agencies that design technical solutions. Germany does the opposite. Berlin invests massively in research on green hydrogen and electrical storage. This asymmetry will be paid for in ten years when France imports the German patents it could have developed.
2.22% of GDP: The 3% Target Moves Further Away Each Year
French research and development spending reaches 2.22% of GDP in 2025, according to the latest OECD estimates. This ratio has stagnated since 2020 while the research programming law promised 3% by 2030. At this pace, France will not reach this target until 2045.
This mediocre performance places France in 11th place in Europe, behind Germany (3.13%), Austria (3.09%) and even Belgium (2.89%). More concerning: the gap widens. When Berlin increases its R&D investments, Paris reduces them over the same period.
The French private sector invests less in research than its European counterparts: 1.38% of GDP against 2.14% in Germany and 1.89% in the United Kingdom. This weakness feeds on itself. Innovative companies establish themselves where public research is strong. By weakening its universities and laboratories, France pushes private investors toward Berlin or London.
South Korea invests 4.8% of its GDP in R&D, Israel 5.4%. These countries understand that fundamental research conditions future prosperity. France prefers to balance its accounts in the short term rather than prepare its long-term competitiveness.
Berlin and London Reinvest, Paris Divests
Germany and the United Kingdom are drawing lessons from their past mistakes. Berlin remembers the stagnation of the 2000s, when German research was losing ground to the United States. The “Excellence Strategy” plan launched in 2019 injects billions of euros over ten years into Germany’s best universities. Results follow: Germany wins significantly more Nobel Prizes than France in recent years.
London is correcting the damage from Brexit that drove European researchers away. The “Future Leaders Fellowships” program allocates 900 million pounds over five years to attract global talent. The strategy is bearing fruit: British scientific publications progress despite leaving Horizon Europe.
These two countries apply a simple rule: strong public research attracts private research. The laboratories of Volkswagen, BASF and SAP establish themselves near German universities funded by the Excellence Strategy. Google DeepMind and Oxford Sciences Innovation R&D centers benefit from British public investments.
France does exactly the opposite. It weakens its public research and wonders why innovative companies shun it. Total Energies relocates its hydrogen teams to Germany, Sanofi its laboratories to the United Kingdom. These departures deprive France of the multiplier effect between public and private research that gives its neighbors their strength.
When French Scientific Excellence Goes into Exile
The consequences of this under-investment show in international rankings. France has 4 universities in the top 100 worldwide in the Times Higher Education 2025, compared to 7 in Germany and 11 in the United Kingdom. More serious: a growing number of French doctoral students leave to finish their thesis abroad.
This brain drain accelerates. Young French researchers massively join better-funded German and British laboratories. The Marie Skłodowska-Curie program finances far more scholarships for French people working in Germany than for foreigners coming to France. The French scientific migration balance becomes negative.
The impact extends beyond fundamental research. French startups struggle to recruit engineers trained at the cutting edge. They establish themselves in Berlin or London to access the talent France no longer trains sufficiently. This downward spiral threatens France’s position in future technologies: artificial intelligence, biotechnologies, quantum computing.
Generative AI adopted everywhere, productive nowhere, but the countries that will train the next AI engineers will dominate tomorrow’s markets. By weakening its research, France mortgages its technological sovereignty for decades to come.
The Political Cost of Scientific Decline
This budgetary erosion is not a technical inevitability but an assumed political choice. The government favors immediate accounting balance over future investment. This short-termist vision ignores a simple economic reality: each euro invested in public research generates four euros of GDP over twenty years, according to OECD calculations.
Germany and the United Kingdom understand this. Their leaders defend research budgets before their respective parliaments by showing the economic returns. France does the opposite: it justifies cuts through budgetary orthodoxy without measuring their future cost.
This political myopia will cost future generations dearly. The technologies developed today in German and British laboratories will bring these countries prosperity in twenty years. France will have to import them at high cost, suffering the dependence it could have avoided.
The awakening will be brutal when French companies discover they depend on foreign patents for their innovations. But it will be too late to catch up on a decade of missed investments in researcher training and laboratory equipment.
France can still reverse this trajectory. Berlin and London show the way: invest massively in public research to attract private research. But the window is closing. Each year of under-investment digs a gap that will take decades to fill. The choice is simple: accept French scientific decline or give research the means of its excellence. The answer will determine France’s place in the global economy of 2040.